Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
Wayne Hall, Louisa Degenhardt, Maree Teesso. Cannabis use and psychotic disorders: an update. Drug and alcohol review. vol 23. issue 4. 2005-04-22. PMID:15763748. |
it seems more likely that cannabis use can precipitate schizophrenia in vulnerable individuals. |
2005-04-22 |
2023-08-12 |
Not clear |
Xavier Laqueill. [Related, induced and associated psychiatric disorders to cannabis]. La Revue du praticien. vol 55. issue 1. 2005-04-21. PMID:15801394. |
cannabis use could be closely linked with the neurobiology of schizophrenia. |
2005-04-21 |
2023-08-12 |
Not clear |
Marie-Odile Krebs, Celine Goldberger, Alain Dervau. Cannabis use and schizophrenia. The American journal of psychiatry. vol 162. issue 2. 2005-03-17. PMID:15677615. |
cannabis use and schizophrenia. |
2005-03-17 |
2023-08-12 |
Not clear |
Darryl Wad. Cannabis use and schizophrenia. The American journal of psychiatry. vol 162. issue 2. 2005-03-17. PMID:15677616. |
cannabis use and schizophrenia. |
2005-03-17 |
2023-08-12 |
Not clear |
Michael T Compton, Andrew C Furman, Nadine J Kaslo. Preliminary evidence of an association between childhood abuse and cannabis dependence among African American first-episode schizophrenia-spectrum disorder patients. Drug and alcohol dependence. vol 76. issue 3. 2005-02-10. PMID:15561482. |
childhood physical and sexual abuse may be a risk factor for the initiation of cannabis dependence and other substance use disorders in the early course of schizophrenia. |
2005-02-10 |
2023-08-12 |
Not clear |
F Markus Leweke, Christoph W Gerth, Joachim Klosterkötte. Cannabis-associated psychosis: current status of research. CNS drugs. vol 18. issue 13. 2005-02-04. PMID:15521792. |
interestingly, the recently suggested role of the endogenous cannabinoid system in schizophrenia not related to previous cannabinoid consumption introduces an additional perspective on the mechanism underlying cannabis-associated schizophrenia-like disorders, as well as on the effects of cannabis consumption in schizophrenia. |
2005-02-04 |
2023-08-12 |
Not clear |
Michael T Compton, Andrew C Furman, Nadine J Kaslo. Lower negative symptom scores among cannabis-dependent patients with schizophrenia-spectrum disorders: preliminary evidence from an African American first-episode sample. Schizophrenia research. vol 71. issue 1. 2005-01-11. PMID:15374573. |
substance use disorders, especially cannabis abuse and dependence, are common comorbid diagnoses among patients in the early course of schizophrenia. |
2005-01-11 |
2023-08-12 |
Not clear |
Maria C Jockers-Scherübl, Heidi Danker-Hopfe, Richard Mahlberg, Franziska Selig, Johannes Rentzsch, Falk Schürer, Undine E Lang, Rainer Hellwe. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse. Neuroscience letters. vol 371. issue 1. 2005-01-03. PMID:15500971. |
drug-naive schizophrenic patients without cannabis consumption showed similar results to normal controls and cannabis controls without schizophrenia. |
2005-01-03 |
2023-08-12 |
Not clear |
Harold Kalan. Adverse effects of cannabis on health: an update of the literature since 1996. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 5. 2004-12-30. PMID:15363608. |
several different studies indicate that the epidemiological link between cannabis use and schizophrenia probably represents a causal role of cannabis in precipitating the onset or relapse of schizophrenia. |
2004-12-30 |
2023-08-12 |
Not clear |
Peter Allebec. [Cannabis can double the risk of schizophrenia. Increasing but still controversial knowledge of the psychological effects of the drug]. Lakartidningen. vol 101. issue 41. 2004-11-16. PMID:15517706. |
[cannabis can double the risk of schizophrenia. |
2004-11-16 |
2023-08-12 |
Not clear |
W Cahn, H E Hulshoff Pol, E Caspers, N E M van Haren, H G Schnack, R S Kah. Cannabis and brain morphology in recent-onset schizophrenia. Schizophrenia research. vol 67. issue 2-3. 2004-06-28. PMID:14984893. |
cannabis and brain morphology in recent-onset schizophrenia. |
2004-06-28 |
2023-08-12 |
Not clear |
N Berge. [Cannabis and schizophrenia. From euphoria to psychosis]. Revue medicale de Liege. vol 59. issue 2. 2004-06-10. PMID:15112899. |
[cannabis and schizophrenia. |
2004-06-10 |
2023-08-12 |
Not clear |
N Berge. [Cannabis and schizophrenia. From euphoria to psychosis]. Revue medicale de Liege. vol 59. issue 2. 2004-06-10. PMID:15112899. |
this observation leads one to question a relationship of cause and effect between cannabis and schizophrenia and of impact of cannabis on the course of this disease. |
2004-06-10 |
2023-08-12 |
Not clear |
Filip Smit, Linda Bolier, Pim Cuijper. Cannabis use and the risk of later schizophrenia: a review. Addiction (Abingdon, England). vol 99. issue 4. 2004-06-04. PMID:15049742. |
cannabis use and the risk of later schizophrenia: a review. |
2004-06-04 |
2023-08-12 |
Not clear |
Katerina Zavitsanou, Therese Garrick, Xu Feng Huan. Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia. Progress in neuro-psychopharmacology & biological psychiatry. vol 28. issue 2. 2004-05-28. PMID:14751433. |
previous studies suggest that long-term cannabis use causes cognitive impairment, including lack of motivation and impaired attention, conditions that also resemble core negative symptoms of schizophrenia. |
2004-05-28 |
2023-08-12 |
human |
Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
long-term cannabis abuse may increase the risk of schizophrenia. |
2004-05-07 |
2023-08-12 |
Not clear |
Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
we tested the hypothesis that damage to neuronal cells in schizophrenia is precipitated by the consumption of cannabis and other neurotoxic substances, resulting in raised ngf serum concentrations and a younger age for disease onset. |
2004-05-07 |
2023-08-12 |
Not clear |
Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
on average, heavy cannabis consumers suffered their first episode of schizophrenia 3.5 years (n = 21) earlier than schizophrenic patients who abstained from cannabis. |
2004-05-07 |
2023-08-12 |
Not clear |
Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
these results indicate that cannabis is a possible risk factor for the development of schizophrenia. |
2004-05-07 |
2023-08-12 |
Not clear |
Maria C Jockers-Scherübl, Uta Matthies, Heidi Danker-Hopfe, Undine E Lang, Richard Mahlberg, Rainer Hellwe. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients. Journal of psychopharmacology (Oxford, England). vol 17. issue 4. 2004-05-07. PMID:14870957. |
this might be reflected in the raised ngf-serum concentrations when both schizophrenia and long-term cannabis abuse prevail. |
2004-05-07 |
2023-08-12 |
Not clear |